Net profit of Rossari Biotech rose 7.36% to Rs 24.08 crore in the quarter ended March 2022 as against Rs 22.43 crore during the previous quarter ended March 2021. Sales rose 101.14% to Rs 438.93 crore in the quarter ended March 2022 as against Rs 218.22 crore during the previous quarter ended March 2021. For the full year,net profit rose 21.75% to Rs 97.67 crore in the year ended March 2022 as against Rs 80.22 crore during the previous year ended March 2021. Sales rose 109.06% to Rs 1482.97 crore in the year ended March 2022 as against Rs 709.35 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 438.93 | 218.22 | 101 | 1482.97 | 709.35 | 109 |
OPM % | 11.92 | 16.52 | – | 12.37 | 17.42 | – |
PBDT | 50.81 | 37.29 | 36 | 184.33 | 129.67 | 42 |
PBT | 34.27 | 29.91 | 15 | 136.28 | 106.84 | 28 |
NP | 24.08 | 22.43 | 7 | 97.67 | 80.22 | 22 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.